U.S. patent application number 13/913992 was filed with the patent office on 2013-10-17 for drug delivery chip and fabricating method thereof.
The applicant listed for this patent is National Taiwan University. Invention is credited to Pen-Li Huang, Yu-Jie Huang, Hsin-Hung Liao, Chii-Wann Lin, Shey-Shi Lu, Tao Wang, Yao-Hong Wang, Yao-Joe Yang.
Application Number | 20130274665 13/913992 |
Document ID | / |
Family ID | 43301270 |
Filed Date | 2013-10-17 |
United States Patent
Application |
20130274665 |
Kind Code |
A1 |
Lu; Shey-Shi ; et
al. |
October 17, 2013 |
DRUG DELIVERY CHIP AND FABRICATING METHOD THEREOF
Abstract
A drug-delivery chip and a method of fabricating the same are
provided. The drug-delivery chip has a main body having at least
one drug receiving space individually formed with an opening for
storing drugs therein; a thin film for sealing up the at least one
drug receiving space; a first conductive wire connecting to one end
of the thin film; a second conductive wire connecting to another
end of the thin film; a signal-receiving module for receiving
actuated signals; and a control module for applying voltages to
first and second wire conductive s according to the actuated
signal, thereby generating heat to break off the thin film for the
release of a drug or drugs received in the at least one drug
receiving space.
Inventors: |
Lu; Shey-Shi; (Taipei,
TW) ; Yang; Yao-Joe; (Taipei, TW) ; Huang;
Yu-Jie; (Taipei, TW) ; Lin; Chii-Wann;
(Taipei, TW) ; Liao; Hsin-Hung; (Taipei, TW)
; Wang; Tao; (Taipei, TW) ; Huang; Pen-Li;
(Taipei, TW) ; Wang; Yao-Hong; (Taipei,
TW) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
National Taiwan University |
Taipei |
|
TW |
|
|
Family ID: |
43301270 |
Appl. No.: |
13/913992 |
Filed: |
June 10, 2013 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
12695516 |
Jan 28, 2010 |
8460564 |
|
|
13913992 |
|
|
|
|
Current U.S.
Class: |
604/113 |
Current CPC
Class: |
A61M 2205/3569 20130101;
A61M 5/14 20130101; A61M 5/172 20130101; A61M 5/14276 20130101;
A61M 2205/3523 20130101 |
Class at
Publication: |
604/113 |
International
Class: |
A61M 5/14 20060101
A61M005/14 |
Foreign Application Data
Date |
Code |
Application Number |
Jun 6, 2009 |
TW |
98118885 |
Claims
1. A drug-delivery chip, comprising: a main body having at least
one drug receiving space individually formed with an opening; a
thin film for sealing up the opening of the at least one drug
receiving space; a first conductive wire connected to one end of
the thin film; a second conductive wire connected to another end of
the thin film; a signal-receiving module for receiving actuated
signals; and a control module for applying voltages to the first
conductive wire and the second conductive wire according to the
actuated signals, thereby generating heat to break off the thin
film for releasing a drug received in the at least one receiving
space from the opening.
2. The drug-delivery chip of claim 1, wherein the actuated signals
include check codes for the control module to identify whether the
actuated signals are valid.
3. The drug-delivery chip of claim 1, wherein the thin film is a
metal thin film.
4. The drug-delivery chip of claim 3, further comprising a
plurality of drug receiving spaces and a plurality of switching
units which are electrically connected to the control module and
connected in one-to-one manner to the first conductive wires and
the second conductive wires which are connected to the metal thin
films sealing up the openings of the drug receiving spaces, wherein
the actuated signals comprise address codes and the control module
correspondingly turns on one of the switching units according to
the address codes of the actuated signals so as to supply power to
the first conductive wire and the second connective wire
electrically connected to the turned-on one of the switching units,
enabling the metal thin film connected to the first conductive wire
and the second connective wire supplied with the power to be broken
off, and allowing the one of the drug receiving spaces
corresponding to the broken-off metal thin film to release the drug
from the opening thereof.
5. The drug-delivery chip of claim 4, wherein the actuated signals
further comprise check codes for the control module to identify
whether the actuated signals are valid.
6. The drug-delivery chip of claim 3, wherein the resistance of the
metal thin film is greater than the resistance of the first
conductive wire or the second conductive wire.
7. The drug-delivery chip of claim 1 being a system-on-a-chip (SoC)
fabricated by a CMOS process.
8. A drug-delivery chip, comprising: a main body having at least
one drug receiving space individually formed with an opening; a
first conductive wire connected to a side wall of the at least one
drug receiving space; a second conductive wire connected to another
side wall of the at least one drug receiving space and spaced from
the first conductive wire; a thin film for sealing up the opening
of the at least one drug receiving space; a signal-receiving module
for receiving actuated signals; and a control module for applying
voltages to the first conductive wire and the second conductive
wire according to the actuated signals, thereby electrolyzing a
drug received in the at least one drug receiving space and
generating air to break off the thin film for releasing the drug
from the opening of the at least one receiving space.
9. The drug-delivery chip of claim 8, wherein the side wall of the
at least one drug receiving space connected to the first conductive
wire is identical to the another side wall of the at least one drug
receiving space connected to the second conductive wire.
10. The drug-delivery chip of claim 8, wherein the side wall of the
at least one drug receiving space connected to the first conductive
wire is opposed to the another side wall of the at least one drug
receiving space connected to the second conductive wire.
11. The drug-delivery chip of claim 8, wherein the actuated signals
comprise check codes for the control module to identify whether the
actuated signals are valid.
12. The drug-delivery chip of claim 8, wherein the thin film is a
protection layer of the drug-delivery chip.
13. The drug-delivery chip of claim 12, further comprising a
plurality of drug receiving spaces and a plurality of switching
units which are electrically connected to the control module and
connected in one-to-one manner to the first conductive wires and
the second conductive wires installed on either of the side walls
of the drug receiving spaces, wherein the actuated signals comprise
address codes and the control module correspondingly turns on one
of the switching units according to the address codes of the
actuated signals so as to supply power to the first conductive wire
and the second connective wire electrically connected to the
turned-on one of the switching units, enabling the protection layer
to be broken off, and allowing the drug receiving spaces
corresponding to the broken-off protection layer to release the
drug.
14. The drug-delivery chip of claim 13, wherein the actuated
signals further comprise check codes for the control module to
identify whether the actuated signals are valid.
15. The drug-delivery chip of claim 8 being an SoC fabricated by a
CMOS process.
16-22. (canceled)
Description
BACKGROUND OF THE INVENTION
[0001] 1. Field of the Invention
[0002] This invention relates to drug-delivery chips and methods of
fabricating the same, and more particularly, to a drug-delivery
chip and a method of fabricating the drug-delivery chip which
employ a semiconductor rear fabrication process technique.
[0003] 2. Description of Related Art
[0004] The advance of technologies brings a great convenience to
ordinary people, but it also contaminates the environment and
increases the possibility that people get ill. In the early age,
people suffer from short lifespan because the medical instruments
are not mature or popular and people cannot be well treated when
getting ill. As the medical technology makes a lot of progress in
recent years, people live healthier and longer than they did
before, and the population of the senior citizens increases
dramatically, which booms the need of a variety of medicines.
[0005] People may buy non-prescription medicines, such as a
drinking medicine, dropping medicine and external medicine, at a
drugstore and take these drugs by themselves. A chronic disease
patient such as a hypertension patient has to take oral
anti-hypertension drugs regularly. A diabetes patient has to take
oral hypoglycemic drugs or even gets a shot of insulin. A
cardiopathy patient has to take medicines regularly, especially in
a moment when a heart attack happens.
[0006] Taking oral drugs or getting a shot of drugs regularly is
vitally important for the chronic disease patients, critically ill
patients and those who needs to take certain drugs, especially for
the senior citizens who suffer from many kinds of illness and have
to take as many as eight pills of drugs every day. Sometimes they
forgot taking medicines, or forgot that they have already took the
medicines and took the medicines a second time.
[0007] Cancer is one of the leading death causes for human. In
addition to the electrotherapy, chemotherapy and surgical
operation, the treatment to cancer also includes taking cancer
drugs and analgesia medicine regularly. The drugs are swallowed and
absorbed by human body through the digestive system, or are
injected into the veins and reach the affected region via the blood
circulation. The drugs are thus diluted. In order to reach the
treatment dosage requirement, the patient has to take a variety of
drugs and suffers from painful side effects.
[0008] A drug-delivery controlling circuit is developed for the
treatment of cancer. The drug-delivery controlling circuit controls
the delivery of drugs by connecting a circuit board to a controller
and/or a signal receiver. The drug-delivery controlling circuit can
be implanted into human body via a surgical operation, for the
treatment of cancer. However, the prior art has the following
problems:
[0009] (1) high cost--since the controller and the signal receiver
have to be fabricated individually and a drug storage part
controlled by the controller is integrated into the circuit
board;
[0010] (2) bulky volume--since the controller, the signal receiver
and the drug storage part are all connected to the circuit board
and packaged together, such a bulky package cannot be implanted
into human body easily and, even if it can be implanted into human
body, if will make harmful impacts on human body; and
[0011] (3) cannot provide a variety of drugs--since the controller,
the signal receiver and the drug storage part controlled by the
controller are all connected to the circuit board, the circuit
board is limited to have a small size, such that the requirement of
providing a variety of drugs cannot be met.
[0012] Therefore, how to provide a drug-delivery technique that is
miniaturized, has a low cost and can be remotely control to deliver
drugs at predetermined time and in determined kinds is becoming one
of the most urgent issues in the art.
SUMMARY OF THE INVENTION
[0013] In view of the above-mentioned problems of the prior art,
the present invention provides a miniaturized drug-delivery chip
and a method of fabricating the same.
[0014] According to a embodiment of the present invention, the
drug-delivery chip includes a main body having at least one drug
receiving space individually formed with an opening; a thin film
for sealing up the opening of the at least one drug receiving
space; a first conductive wire connected to one end of the thin
film; a second conductive wire connected to another end of the thin
film; a signal-receiving module for receiving actuated signals; and
a control module for applying voltages to the first conductive wire
and then the second conductive wire according to the actuated
signals, thereby generating heat to break off the thin film for the
release of a drug (or drugs) received in the at least one receiving
space from the opening.
[0015] According to another embodiment of the present invention,
the present invention provides a drug-delivery chip that includes a
main body having at least one drug receiving space individually
formed with an opening; a first conductive wire connected to a side
wall of the at least one drug receiving space; a second conductive
wire connected to another side wall of the at least one drug
receiving space and spaced from the first conductive wire; a thin
film for sealing up the opening of the at least one drug receiving
space; a signal-receiving module for receiving actuated signals;
and a control module for applying voltages to the first conductive
wire and the second conductive wire according to the actuated
signals, thereby electrolyzing a drug (or drugs) received in the at
least one drug receiving space and generating air to break off the
thin film for the release of the drugs from the opening of the at
least one receiving space,
[0016] The method of fabricating the drug-delivery chip includes
the steps of: providing a substrate having a stack structure formed
on a first surface of the substrate, the stack structure having an
insulation layer, a conductive wire layer having void spaces, and a
protection layer; etching the protection layer at a position
corresponding to the void spaces of the conductive wire layer to
form an opening; forming a metal thin film on the conductive wire
layer to seal up the opening, wherein the metal thin film has two
ends respectively connected to the conductive wire layer on each of
two sides of the opening and is electrically connected to a control
module via the conductive wire layer; etching the substrate and the
insulation layer to form a drug receiving space and expose the
metal thin film; filling the drug receiving space with a drug (or
drugs); and installing a sealing film on a second surface of the
substrate to seal up the drug filled in the drug receiving
space,
[0017] The present invention further provides a method of
fabricating the drug-delivery, including the steps of: providing a
substrate having a stack structure on a first surface of the
substrate, the stack structure having an insulation layer, a
conductive wire layer having void spaces, and a protection layer;
etching the substrate and the insulation layer at a position
corresponding to the void spaces of the conductive wire layer to
form a drug receiving space; filling the drug receiving space with
a drug (drugs); and installing a sealing film on a second surface
of the substrate to seal up the drugs filled in the drug receiving
space.
[0018] Compared with the prior art, the present invention provides
a drug-delivery chip and a method of fabricating the same, which
employ a semiconductor rear fabrication process technique to form a
drug receiving space on a drug-delivery chip having a control
module and a signal-receiving module, so as to achieve the
effectiveness of miniaturization, low cost, and the controlling of
the drug-delivery time and the kind of drugs to be delivered.
BRIEF DESCRIPTION OF DRAWINGS
[0019] FIG. 1A is a schematic diagram of a drug-delivery chip of an
embodiment according to the present invention;
[0020] FIG. 1B is a schematic diagram of a drug-delivery chip of
another embodiment according to the present invention;
[0021] FIG. 2 is a functional block diagram of a drug-delivery chip
cooperating with a signal transmitter of an embodiment according to
the present invention;
[0022] FIGS. 3A-3I are schematic diagrams of a method of
fabricating a drug-delivery chip of an embodiment according to the
present invention;
[0023] FIG. 4 is a schematic diagram illustrating a step of
enlarging a drug receiving space of the drug-delivery chip shown in
FIG. 3I;
[0024] FIGS. 5A and 5B are schematic diagrams illustrating the way
that the drug-delivery chip fabricated by the method shown in FIGS.
3A-3I releases drugs;
[0025] FIGS. 6A-6D are schematic diagrams of a method of
fabricating a drug-delivery chip of another embodiment according to
the present invention;
[0026] FIG. 7 is a schematic diagram illustrating a step of
enlarging a drug receiving space of the drug-delivery chip shown in
FIG. 6D;
[0027] FIGS. 8A and 8B are schematic diagrams illustrating the way
that the drug-delivery chip fabricated by the method shown in FIGS.
6A-6D releases drugs; and
[0028] FIG. 9 is a schematic diagram illustrating the packaging of
a drug-delivery chip of an embodiment according to the present
invention.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[0029] The following illustrative embodiments are provided to
illustrate the disclosure of the present invention, these and other
advantages and effects can be apparently understood by those in the
art after reading the disclosure of this specification. The present
invention can also be performed or applied by other different
embodiments. The details of the specification may be on the basis
of different points and applications, and numerous modifications
and variations can be devised without departing from the spirit of
the present invention.
[0030] Please refer to FIG. 1A, which is a schematic diagram of a
drug-delivery chip of an embodiment according to the present
invention. Preferably, the drug-delivery chip of the present
invention is a system-on-a-chip (SoC) fabricated by a 0.35 .mu.m
CMOS process, and has a size of 1.77 mm.times.1.4 mm.
[0031] In the embodiment of the present invention, the
drug-delivery chip comprises a main body 2a having at lease a drug
receiving space 215 for storing drugs therein, a thin film 24a for
sealing up an opening 215a of the drug receiving space 215, a first
conductive wire 23a connected to one end of the thin film 24a, a
second conductive wire 23b connected to another end of the thin
film 24a, a signal-receiving module 213 for receiving actuated
signals, and a control module 214 for controlling the release of
the drugs received in the drug receiving space 215 according to the
actuated signals.
[0032] In an embodiment of the present invention, the thin film 24a
is a metal thin film, In practice, when the signal-receiving module
213 receives the actuated signals, the control module 214 applies
voltages to the first conductive wire 23a and the second conductive
wire 23b, allowing currents to pass through the first conductive
wire 23a and the second conductive wire 23b. In consequence, the
drugs can be released from the opening 215a of the drug receiving
space 215, since the heat generated by the first conductive wire
23a and the second conductive wire 23b accumulates on the metal
thin film 24a and eventually breaks off the metal thin film
24a.
[0033] Please refer to FIG. 1B, which is a schematic diagram of a
drug-delivery chip of another embodiment according to the present
invention. In the another embodiment of the present invention, the
drug-delivery chip comprises a first conductive wire 23a', a second
conductive wire 23b', a drug receiving space 215', a thin film 24a'
for sealing up an opening 215a' of the drug receiving space 215', a
signal-receiving module 213' for receiving actuated signals, and a
control module 214' for controlling the release of the drugs
received in the drug receiving space 215' according to the actuated
signals. In the another embodiment of the present invention, the
first conductive wire 23a' and the second conductive wire 23b' are
connected to side walls 215b' on two sides of the drug receiving
space 215', respectively. In yet another embodiment of the present
invention, the first conductive wire 23a' and the second conductive
wire 23b' are both connected to an identical side wall of the drug
receiving space 215', such as a bottom surface or the same side
wall. In the another embodiment, the thin film 24a' is a protection
layer of the drug-delivery chip, and the drugs received in the drug
receiving space 215' contain moisture.
[0034] In practice, when the signal-receiving module 213' receives
the actuated signals, the control module 214' applies voltages to
the first conductive wire 23a' and the second conductive wire 23b',
enabling the moisture contained in the drugs received in the drug
receiving space 215' to be electrolyzed and generate bubbles,
leading the thin film 24a' of the drug-delivery chip to be broken
off, such that the drugs can be released from the opening 215a' of
the drug receiving space 215'.
[0035] Note that the drug-delivery chip of the present invention is
not limited to have only one drug receiving space 215 (or 215'), as
shown in FIGS. 1A and 1B. A drug-delivery chip according to the
present invention may have any number of drug receiving spaces 215
(or 215'). Further, the drug receiving space 215 (or 215') may
receive a variety of drugs.
[0036] FIG. 2 is a functional block diagram of a drug-delivery chip
cooperating with a signal transmitter 7 of an embodiment according
to the present invention. Note that the embodiment shown in FIG, 2
is exemplified based on the drug-delivery chip shown in FIG. 1A. As
shown in FIG. 2, the drug-delivery chip of the embodiment comprises
a plurality of drug receiving spaces 215, and a plurality of
switching units 217 connected to the control module 214. The
switching units 217 are further connected to one end of a plurality
of metal thin films 24a for sealing up the drug receiving spaces
215 and a first conductive wire 23a in a one-to-one manner. The
another end of the metal thin films 24a is connected to the second
conductive wire 23b that acts as a ground end. The signal
transmitter 7 is, for example, a remote controller, for
transmitting the actuated signals to the signal-receiving module
213 of the drug-delivery chip. The signal transmitter 7 may be
integrated into an electronic apparatus (not shown), such as a
mobile phone, a personal digital assistant or a computer, that can
transmit the actuated signals.
[0037] Since the drug-delivery chip of the embodiment comprises a
plurality of drug receiving spaces 215, in order for the control
module 214 to identify the actuated signals received and control
the release of the drugs received in any one or more than one of
the drug receiving spaces 215, the actuated signals transmitted by
the signal transmitter 7 may comprise check codes or/and address
codes. Therefore, the control module 214 identifies the check codes
of the actuated signals after the signal-receiving module 213
receives the actuated signals, so as to prevent the drug-delivery
chip, under a circumstance that the wireless communication is
interfered due to external interference signals, from performing
erroneous actions, such as releasing the wrong drugs or releasing
the drugs without any reason. After identifying the check codes to
be correct (which means that the check codes are valid), the
control module 214 turns on the corresponding switching unit 217
according to the address codes of the actuated signals, such that
currents can flow through the turned-on switching unit 217 to the
first conductive wire 23a connected to the turned-on switching unit
217. Therefore, the first conductive wire 23a connected to the
turned-on switching unit 217 is electrified, the metal thin film
24a connected to the electrified first conductive wire 23a is
broken off, and the drug receiving space 215 corresponding to the
broken-off metal thin film 24a can release the drugs.
[0038] Further, the actuated signals further comprise drug-delivery
time messages. The control module 214 receives and stores the
drug-delivery time messages of the actuated signals, and controls
the release of the drugs received in the drug receiving space 215
at predetermined time. Therefore, the drug-delivery time may be set
by transmitting the actuated signals externally at predetermined
time, by appending the drug-delivery time messages to the actuated
signals and transmitting the actuated signals regularly, or
embedding a predetermined drug-delivery time program into the
control module 214 to control the release the drugs received in the
drug receiving space 215.
[0039] Note that in the embodiment shown in FIG. 1A, the thin film
24a is broken off in a current heating and melting way. In this
way, when the control module 214 turns on the corresponding
switching unit 217 according to the address codes of the actuated
signals, currents will flow through the conductive wire 23a and 23b
electrically connected to the turned-on switching unit 217, since
both ends of the metal thin film 24a are connected to the first
conductive wire 23a and the second conductive wire 23b,
respectively. Then, heat generated by the currents accumulates on
the metal thin film 24a and the metal thin film 24a is broken off,
such that the drugs received in the drug receiving space 215 under
the metal thin film 24a may be released. In the embodiment shown in
FIG. 1B, the thin film 24a is broken off in an electrolyzed way. In
this way, the protection layer of the drug-delivery chip is
employed as the thin film to seal up the drug receiving space 215'.
Since the first conductive wire 23a' and the second conductive wire
23b' are connected to the side wall 215b' of the drug receiving
space 215', when the control module 214' turns on the corresponding
switching unit 217' according to the address codes of the actuated
signals, currents will flow through the conductive wire 23a' and
23b' electrically connected to the turned-on switching unit 217',
leading the moisture contained in the drugs received in the drug
receiving space 215' to be electrolyzed and generate enough bubbles
to break off the protection layer 24a'. Therefore, the drugs may be
released from the drug receiving space 215' under the protection
layer.
[0040] It can be known from the above embodiments that the
drug-delivery chip according to the present invention integrates
the control module and the signal-receiving module with the drug
receiving space, so as to achieve the objectives of
miniaturization, low cost and the controlling of drug-delivery time
and the kind of the drugs to be delivered.
[0041] Please refer to FIGS. 3A-3I, which are schematic diagrams
illustrating a method of fabricating a drug-delivery chip of an
embodiment according to the present invention. The method of
fabricating the drug-delivery chip is applicable to the fabrication
of a drug-delivery chip that releases drugs received in a drug
receiving space in a current heating and melting way.
[0042] The step shown in FIG. 3A is executed first: providing a
main body 20, the main body 20 comprising a substrate 21 having a
first surface 210 and a second surface 211 opposed to the first
surface 210, an insulation layer 22 (e.g., an oxide layer or
nitride) installed on the first surface 210 of the substrate 21, a
conductive wire layer 23 installed on the insulation layer 22 and
having void spaces 230, and a protection layer 24 that covers the
conductive wire layer 23.
[0043] A first masking layer 1' is installed on the protection
layer 24 of the main body 20. The first masking layer 1' has breach
patterns corresponding to the position of the void spaces 230 of
the conductive wire layer 23, for exposing the protection layer
24.
[0044] The step shown in FIG. 3B is executed next: etching the
protection layer 24 with a reactive ion etching (RIE) technique, to
expose the void spaces 230 of the conductive wire layer 23 and the
insulation layer 22 under the void spaces 230, and removing the
first masking layer 1'.
[0045] The step shown in FIG. 3C is executed next: covering the
protection layer 24 with a second masking layer 2'.
[0046] The step shown in FIG. 3D is executed next: forming a metal
thin film 25, with an evaporation technique, on the second masking
layer 2' and on the conductive wire layer 23 and the void spaces
230 of the conductive wire layer 23 that expose to a region outside
of the protection layer 24, and connecting both ends of the metal
thin film 25 to the conductive wire layer 23 on two ends of the
void spaces 230, respectively.
[0047] The step shown in FIG. 3E is executed next: removing the
second masking layer 2' with a lift-off technique.
[0048] The step shown in FIG. 3F is executed next: installing a
third masking layer 3' on the second surface 211 of the substrate
21, the third masking layer 3' having breach patterns corresponding
to the position of the void spaces 230 of the conductive wire layer
23, etching the substrate 21 and the insulation layer 22 with an
etching technique to expose a part of the metal thin film 25 that
is formed in the void spaces 230 of the conductive wire layer 23
and toward the substrate 21, and forming among the substrate 21,
the insulation layer 22 and metal thin film 25 a drug receiving
space 26 for storing drugs therein.
[0049] The substrate 21 is etched by an inductively-coupled plasma
(ICP) technique, while the insulation layer 22 is etched by a
reactive ion etching (RIE) technique. Before the above etching
techniques are performed, a chemical-mechanical polishing (CMP)
technique may be employed to polish the second surface 211 of the
substrate 21, so as to thin the substrate 21 and speed up the
etching.
[0050] The step shown in FIG. 3G is executed next: removing the
third masking layer 3'.
[0051] The step shown in FIG. 3H is executed next: filling the drug
receiving space 26 with drugs 27.
[0052] The step shown in FIG. 31 is executed next: installing a
thin film 28 on the second surface 211 of the substrate 21 to seal
up the drugs 27 filled in the drug receiving space 26.
[0053] Please refer to FIG. 4, which is a schematic diagram
illustrating a step of enlarging the drug receiving space 26 of the
drug-delivery chip. As shown in FIG. 4, a plate layer 29 is
installed on the second surface 211 of the substrate 21 at a side
edge opposed to a position where the drug receiving space 26 is
formed, to enlarge the storage capacity of the drug receiving space
26. The thin film 28 is further installed to seal up the drugs 27
filled in the drug receiving space 26.
[0054] In the method of fabricating a drug-delivery chip shown in
FIG. 3A, the breach patterns of the first masking layer 1' are not
limited to correspond to the position of the void spaces 230 of the
conductive wire layer 23. The breach patterns of the first masking
layer 1' may be installed to correspond to a position of the two
conductive wire layers 23, which is in an open state after the
first masking layer 1' is etched and is in a close state after the
metal thin film 25 is formed and is supplied with electricity.
[0055] FIGS. 5A and 5B illustrate the way that the drug-delivery
chip fabricated by the method of fabricating a drug-delivery chip
releases drugs.
[0056] As shown in FIG. 5A, the control module applies voltages to
the conductive wire layer 23 according to the actuated signals.
[0057] As shown in FIG. 5B, break off the metal thin film 25 that
is connected to the conductive wire layer 23 and covers the drug
receiving space 26 to release the drugs 27 received in the drug
receiving space 26.
[0058] It can be known from FIGS. 3A-3I, FIG. 4 and FIGS. 5A-5B
that the position of the void spaces 230 of the conductive wire
layer 23 is selected as the releasing exits for the drugs received
in the drug receiving space 26. If the drug-delivery chip has a
plurality of drug receiving spaces 26, the drug-delivery chip may
further comprise a plurality of switching units connected in a
one-to-one manner to the plurality of the drug receiving spaces 26,
When the signal-receiving module receives the actuated signals that
have check codes, address codes and/or predetermined time messages,
the control module turns on the corresponding switching unit at
predetermined time according to the actuated signals, such that
currents will flow through the metal thin film 25 that is connected
to the conductive wire layer 23 and covers the drug receiving space
26, leading the metal thin film 25 to be broken off for the drugs
27 to be released.
[0059] The metal thin film 25 is broken off because of the passing
of great enough currents through the metal thin film 25. Since the
metal thin film 25 is far thinner than the conductive wire layer 23
and the metal thin film 25 has a resistance far greater than a
resistance of the conductive wire layer 23, when the great enough
currents are passing, a great amount of heat will be generated and
accumulate on the metal thin film 25, and break the metal thin film
25 eventually, such that the drugs 27 may be released. The drugs 27
are in a solid state (powder) or in a liquid state.
[0060] FIGS. 6A-6D are schematic diagrams of a method of
fabricating a drug-delivery chip of another embodiment according to
the present invention. The method of fabricating a drug-delivery
chip is applicable to the fabrication of a drug-delivery chip that
releases drugs received in a drug receiving space in an
electrolyzed way.
[0061] The step shown in FIG. 6A is executed first: providing a
main body 20' that comprises a substrate 21' having a first surface
210' and a second surface 211' opposed to the first surface 210',
an insulation layer 22' installed on the first surface 210' of the
substrate 21', a conductive wire layer 23' installed on the
insulation layer 22', and a protection layer 24' that covers the
conductive wire layer 23'.
[0062] A first masking layer 1'' is installed at a predetermined
position on the second surface 211' of the substrate 21' of the
main body 20'. The first masking layer 1'' has breach patterns. A
part of the protection layer 24' toward the first surface of the
substrate 21' is exposed by etching the substrate 21' and the
insulation layer 22' with an etching technique, and a drug
receiving space 26' is formed among the substrate 21', the
insulation layer 22', the conductive wire layer 23' and the
protection layer 24' for storing drugs.
[0063] The substrate 21' is etched by an inductively-coupled plasma
technique, while the insulation layer 22' is etched by a
wet-etching technique. Before the above etching techniques are
performed, a chemical-mechanical polishing technique may be
employed to polish the second surface 211' of the substrate 21', so
as to thin the substrate 21' and speed up the etching.
[0064] The step shown in FIG. 6B is executed next: removing the
first masking layer 1''. The step shown in FIG. 6C is executed
next: filling the drug receiving space 26' with drugs 27'.
[0065] The step shown in FIG. 6D is executed next: installing on
the second surface 211' of the substrate 21' a sealing film 28' for
sealing up the drugs 27' filled in the drug receiving space
26'.
[0066] Please refer to FIG. 7, which is a schematic diagram
illustrating a step of enlarging the drug receiving space 26' of
the drug-delivery chip. As shown in FIG. 7, a plate layer 29' is
installed on the second surface 211' of the substrate 21' at a side
edge opposed to a position where the drug receiving space 26' is
formed, to enlarge the storage capacity of the drug receiving space
26'. The sealing film 28' is further installed to seal up the drugs
27' filled in the drug receiving space 26'.
[0067] FIGS. 8A-8B illustrate the way that the drug-delivery chip
fabricated by the method of fabricating a drug-delivery chip shown
in FIGS. 6A-6D releases drugs.
[0068] As shown in FIG, 8A, the control module applies voltages to
the conductive wire layer 23' according to the actuated
signals.
[0069] As shown in FIG. 8B, break off the protection layer 24' that
covers the drug receiving space 26' to release the drugs 27'
received in the drug receiving space 26'.
[0070] If the drug-delivery chip has a plurality of drug receiving
spaces 26', the drug-delivery chip may further comprise a plurality
of switching units connected to the plurality of drug receiving
spaces 26' in a one-to-one manner. When the signal-receiving module
receives the actuated signals that have check codes, address codes
and predetermined time messages, the control module turns on the
corresponding switching unit at predetermined time according to the
actuated signals, so as to generate a voltage on the conductive
wire layer 23', such that the protection layer 24' that covers the
drug receiving space 26' is broken off to release the drugs
27'.
[0071] The protection layer 24' is broken off because when a
current passes through the conductive wire layer 23' the conductive
wire layer 23 forms in the drug receiving space 26' an electric
field that affects the moisture (H.sub.2O) or hydrochloric acid
(HCL) contained in the drugs 27' to be electrolyzed and generate
hydrogen (H.sub.2) and oxygen (O.sub.2) bubbles, the swelled
bubbles breaking off the protection layer 24' to release the drugs
27'.
[0072] In order to speed up the electrolyzed effect, the first
masking layer 1'' shown in FIG. 6A can cover the conductive wire
layer 23' at more positions, allowing the drug receiving space 26'
to be formed in a multi-layered conductive wire layer, such that
currents pass through the multi-layered conductive wire layer and
generate a stronger electric field.
[0073] Through a method of fabricating a drug-delivery chip
according to the present invention, a drug-delivery technique that
has the effectiveness of miniaturization, low cost and the
controlling of the drug-delivery time and the kind of drugs to be
delivered can be achieved. Compared with the drug-delivery method
shown in FIGS. 8A and 8B that employs the electrolyzed way, the
drug-delivery method shown in FIGS. 5A and 5B that employs the
current heating and melting way needs greater currents, and the
amount of the heat generated will be limited to a certain range
that does not affect human body or human cells. On the contrary,
the drug-delivery method that employs the electrolyzed way does not
need great currents. However, in an electrolyzed reaction whether
the ingredients and concentration of drugs are changed because of
the generation of hydrogen and oxygen due to the electrolyzed
reaction has to be considered, while the drugs, through
calculation, can have an accurate concentration after the liquid
leaves the drugs, without affecting the objectives and
effectiveness of the present invention.
[0074] FIG. 9 is a schematic diagram illustrating the packaging of
a drug-delivery chip of an embodiment according to the present
invention, including a top lid 60 having a drug releasing window
601, a drug-delivery chip 61 according to the present invention, a
sealing film 62, a circuit board 63, a battery 64, an antenna 65
and a bottom lid 66.
[0075] In an embodiment of the present invention, the sealing film
62 is made of an organic material, and covers the drug-delivery
chip 61 to seal up the filled drugs; the battery 64 is a chargeable
lithium-ion nanowire battery; the circuit board 63 is electrically
connected to the drug-delivery chip 61 and the battery 64; and the
top lid 60 and the bottom lid 66 are made of a biocompatible
material. Therefore, the drug-delivery chip package can be
implanted into a living body. Thus, drugs, after being released,
will flow to the whole body through the blood circulation, so as to
cure the body. Specifically, the drug-delivery chip can be placed
in a tumor area, and the drugs of high concentration released by
the drug-delivery chip enters the tumor area directly, such that it
is unnecessary to increase of the drug concentration in order for
the drugs to pass the blood disturbance, which makes the living
body feel uncomfortable.
[0076] The battery 64 is a lithium-ion nanowire battery, and may be
charged wirelessly and stores power. Currents provided by the
battery 64 flow through the circuit board 63 to the drug-delivery
chip 61. In operation, the circuit board 63 does not consume much
power. Therefore, the drug-delivery chip and the method of
fabricating the same of the present invention can deliver drugs
constantly, without worrying about the power supplying problem.
[0077] It can be known from the above embodiments that the
application of the drug-delivery chip and the drug-delivery chip
package fabricated by a method of fabricating the drug-delivery
chip has the effectiveness of miniaturization, low cost, the
controlling of drug-delivery time and the kind of drugs to be
delivered and constant power and can be implanted into a living
body.
[0078] Therefore, through the drug-delivery chip and the method of
fabricating the same of the present invention, the following
objectives can be achieved:
[0079] (1) miniaturization and low cost--which is achieved by
integrating a signal-receiving module, a drug receiving space and a
control module into a single drug-delivery chip, so as to solve the
bulky volume and high cost problems of the prior art that employs a
circuit board to electrically connect a controller, a signal
receiver and a drug storage component;
[0080] (2) the controlling of the kind of drugs to be
delivered--which is achieved by the control module, which turns on
the corresponding switching unit according to the check codes and
address codes of the actuated signals, to release the drugs
received in the drug receiving space connected to the turned-on
switching unit, such that a variety of kinds of drugs can be
received in the drug receiving space, depending on various needs;
and
[0081] (3) the controlling of drug-delivery time--which is achieved
by transmitting actuated signals at predetermined time, by
appending predetermined drug-delivery time messages to the actuated
signals and transmitting the actuated signals regularly, or by
embedding a predetermined drug-delivery time program into the
control module for the release of the drugs received in the drug
receiving space.
[0082] In sum, the drug-delivery chip and the method of fabricating
the same of the present invention integrate a signal-receiving
module, a control module and a drug receiving space into a single
drug-delivery chip, which combines wireless signals and external
currents to enable the drugs received in the drug receiving space
to be released, so as to achieve the above objectives and
effectiveness.
[0083] The foregoing descriptions of the detailed embodiments are
only illustrated to disclose the features and functions of the
present invention and not restrictive of the scope of the present
invention. It should be understood to those in the art that all
modifications and variations according to the spirit and principle
in the disclosure of the present invention should fall within the
scope of the appended claims.
* * * * *